Personal information

Activities

Collapse all

Employment (1)

Duke University Hospital: Durham, NC, US

2018-08-01 to present | Clinical Oncology Pharmacist, Breast Oncology
Employment
Source: Self-asserted source
Heather Moore

Works (7)

Effective Strategies for the Prevention and Mitigation of Phosphatidylinositol-3-Kinase Inhibitor-Associated Hyperglycemia: Optimizing Patient Care

Clinical Breast Cancer
2024-09 | Journal article
DOI: 10.1016/j.clbc.2024.09.017
Contributors: Heather N. Moore; Marcus D. Goncalves; Abigail M. Johnston; Erica L. Mayer; Hope S. Rugo; William J. Gradishar; Dylan M. Zylla; Richard M. Bergenstal
Source: check_circle
Crossref

Assessment of efficacy and safety of dose-dense doxorubicin and cyclophosphamide (ddAC) in combination with immunotherapy in early-stage triple-negative breast cancer

Breast Cancer Research and Treatment
2024-08 | Journal article
DOI: 10.1007/s10549-024-07354-2
Contributors: Olivia White; Susan Dent; Kelly Westbrook; Hui-Jie Lee; Chengxin Yang; Heather N. Moore
Source: check_circle
Crossref

Moving Beyond Cardiotoxicity Detection to Prevention: A Pharmacologic Review

Current Treatment Options in Cardiovascular Medicine
2024-01 | Journal article
DOI: 10.1007/s11936-023-01030-2
Contributors: Susan Dent; Ryan K Rader; Olivia White; Brandy Patterson; Heather N. Moore
Source: check_circle
Crossref

Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique

npj Breast Cancer
2024-01-31 | Journal article
DOI: 10.1038/s41523-024-00613-x
Contributors: Emily J. Gallagher; Heather Moore; Mario E. Lacouture; Susan F. Dent; Azeez Farooki; Marcus D. Goncalves; Claudine Isaacs; Abigail Johnston; Dejan Juric; Zoe Quandt et al.
Source: check_circle
Crossref

Real-World Perspectives and Practices for Pneumonitis/Interstitial Lung Disease Associated With Trastuzumab Deruxtecan Use in Human Epidermal Growth Factor Receptor 2–Expressing Metastatic Breast Cancer

JCO Oncology Practice
2023-08 | Journal article
DOI: 10.1200/OP.22.00480
Contributors: Hope S. Rugo; Christine L. Crossno; Yaron B. Gesthalter; Kristen Kelley; Heather N. Moore; Mothaffar F. Rimawi; Kelly E. Westbrook; Saundra S. Buys
Source: check_circle
Crossref

Evaluation of alpelisib-induced hyperglycemia prophylaxis and associated risk factors in PIK3CA-mutated hormone-receptor positive, human epidermal growth factor-2 negative advanced breast cancer

Breast Cancer Research and Treatment
2023-01 | Journal article
DOI: 10.1007/s10549-022-06798-8
Contributors: Sarah E. Burnette; Emily Poehlein; Hui-Jie Lee; Jeremy Force; Kelly Westbrook; Heather N. Moore
Source: check_circle
Crossref

Evaluation of alpelisib-induced hyperglycemia prophylaxis and associated risk factors in PIK3CA-mutated hormone-receptor positive, human epidermal growth factor-2 negative advanced breast cancer

2022-07-20 | Preprint
DOI: 10.21203/rs.3.rs-1772159/v1
Contributors: Sarah Burnette; Emily Poehlein; Hui-Jie Lee; Jeremy Force; Kelly Westbrook; Heather N. Moore
Source: check_circle
Crossref
How many people are using ORCID?